The emerging therapy of this peptide represents a major advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatide-peptide144398.kylieblog.com/42554087/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment